Targeting Ferroptosis in Rare Neurological Disorders Including Pediatric Conditions: Innovations and Therapeutic...

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Ferroptosis, a regulated cell death pathway dependent on iron and lipid peroxidation, is increasingly implicated in neurodegenerative diseases.
• Rare neurological disorders often have limited treatment options and high unmet medical needs, making novel therapeutic targets crucial.

Purpose of the Study:

• To review the role of ferroptosis in the pathogenesis of rare neurological disorders.
• To explore current and emerging pharmacological strategies targeting ferroptosis for therapeutic intervention.
• To discuss the translational and regulatory hurdles in developing ferroptosis-based treatments.

Main Methods:

• Literature review of studies on ferroptosis, neurodegeneration, and rare neurological diseases.
• Analysis of pharmacological agents targeting iron metabolism and lipid peroxidation.
• Examination of challenges in clinical translation and regulatory pathways.

Main Results:

• Ferroptosis contributes to neuronal damage and dysfunction in various rare neurological conditions.
• Pharmacological agents like iron chelators and lipid peroxidation inhibitors show preclinical promise.
• Disease heterogeneity, diagnostic limitations, and small patient populations pose significant challenges.

Conclusions:

• Targeting ferroptosis presents a promising avenue for novel therapies in rare neurological disorders.
• Overcoming translational and regulatory barriers is essential for clinical implementation.
• Further research and innovative solutions are needed to realize the therapeutic potential of ferroptosis inhibition.